STAT | Reporting from the frontiers of health and medicine Follow STAT+: Bristol Myers to buy startup Orbital Therapeutics, building out cell therapy pipeline Bristol Myers Squibb is buying startup Orbital Therapeutics for $1.5 billion, aiming to develop more scalable cell therapies for autoimmune disorders. https://www.statnews.com/2025/10/10/bristol-myers-squibb-orbital-cell-therapy-autoimmune-car-t-in-vivo/ statnews.com
